Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
British Journal of Cancer
|
June 30, 2012
Comment on: 'Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?'
S S Bielack
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2008
State-of-the-art approach in selective curable tumors: bone sarcoma
S S Bielack, D Carrle
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2010
Osteosarcoma
J Ritter, S S Bielack
ESMO Open
|
December 23, 2021
A special jubilee: 100 fake osteosarcoma articles
S S Bielack, E Palmerini
Cancer
|
August 1, 1997
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature
S S Bielack, G Beron, K Winkler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence
S S Bielack, B Kempf-Bielack, K Winkler
Cancer Treatment and Research
|
January 1, 1993
Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?
S S Bielack, P Bieling, R Erttmann, et al.
European Journal of Cancer & Clinical Oncology
|
May 1, 1989
Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy
S S Bielack, R Erttmann, K Winkler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 1996
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
S S Bielack, R Erttmann, B Kempf-Bielack, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 22, 2006
Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project
C A Stiller, S S Bielack, G Jundt, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
British Journal of Cancer
|
June 30, 2012
Comment on: 'Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?'
S S Bielack
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2008
State-of-the-art approach in selective curable tumors: bone sarcoma
S S Bielack, D Carrle
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2010
Osteosarcoma
J Ritter, S S Bielack
ESMO Open
|
December 23, 2021
A special jubilee: 100 fake osteosarcoma articles
S S Bielack, E Palmerini
Cancer
|
August 1, 1997
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature
S S Bielack, G Beron, K Winkler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence
S S Bielack, B Kempf-Bielack, K Winkler
Cancer Treatment and Research
|
January 1, 1993
Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?
S S Bielack, P Bieling, R Erttmann, et al.
European Journal of Cancer & Clinical Oncology
|
May 1, 1989
Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy
S S Bielack, R Erttmann, K Winkler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 1996
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
S S Bielack, R Erttmann, B Kempf-Bielack, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 22, 2006
Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project
C A Stiller, S S Bielack, G Jundt, et al.
Page
of 3